Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan ― Results From Post-Marketing Surveillance (XASSENT) ―
Ikuo Fukuda, Takanori Hayasaki, Kazufumi Hirano(Netherlands Pharmacovigilance Centre Lareb), Tsubasa Tajima(Bay Medical Center), Mashio Nakamura, Takao Kobayashi(Hokkaido University), Michiya Tachiiri(Bay Medical Center), Toshiyuki Sunaya(Health Data Research UK), Yutaka Okayama(Netherlands Pharmacovigilance Centre Lareb), Norikazu Yamada(Tohoku University), Atsushi Hirayama(Nihon University), Hideaki Maeda(Nihon University), Kazuo Kawasugi(Teikyo University)
Cited by 3
Related Papers
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|552
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
|The Journal of Immunology|2011|490
IL-33–activated dendritic cells induce an atypical TH2-type response
|Journal of Allergy and Clinical Immunology|2009|400
Association between the abnormal expression of matrix‐degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions
|Arthritis & Rheumatism|2005|349
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
|Circulation Cardiovascular Quality and Outcomes|2017|336